| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |